MYC Overexpression Confers Sensitivity to TACC3 Inhibition for Triple-Negative Breast Cancer
Mauricio Jacobo Jacobo, July Aung, Christopher O’Brien…·Andrei Goga
This study identifies TACC3 as a vulnerability in MYC-overexpressing triple-negative breast cancers, showing that its inhibition induces cytotoxicity and inflammatory responses.